These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
580 related articles for article (PubMed ID: 31387239)
1. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer. Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer. Gharib E; Nasrinasrabadi P; Zali MR PLoS One; 2020; 15(3):e0229864. PubMed ID: 32155177 [TBL] [Abstract][Full Text] [Related]
3. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001 [TBL] [Abstract][Full Text] [Related]
4. A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer. Low YS; Blöcker C; McPherson JR; Tang SA; Cheng YY; Wong JYS; Chua C; Lim TKH; Tang CL; Chew MH; Tan P; Tan IB; Rozen SG; Cheah PY Cancer Lett; 2017 Sep; 403():13-20. PubMed ID: 28624625 [TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers. Ghatak S; Mehrabi SF; Mehdawi LM; Satapathy SR; Sjölander A Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054980 [TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
7. Identification and validation of an immune prognostic signature in colorectal cancer. Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948 [TBL] [Abstract][Full Text] [Related]
8. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome. Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941 [TBL] [Abstract][Full Text] [Related]
9. Large-Scale Analysis of Gene Expression Data Reveals a Novel Gene Expression Signature Associated with Colorectal Cancer Distant Recurrence. Alajez NM PLoS One; 2016; 11(12):e0167455. PubMed ID: 27935967 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer. Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760 [TBL] [Abstract][Full Text] [Related]
11. A five-immune-related genes-based prognostic signature for colorectal cancer. Zhu L; Wang H; Wang Z Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer. Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841 [No Abstract] [Full Text] [Related]
13. Identification of a five-gene signature with prognostic value in colorectal cancer. Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881 [TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
15. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study. Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062 [TBL] [Abstract][Full Text] [Related]
16. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling. Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927 [TBL] [Abstract][Full Text] [Related]
17. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer. Xu K; He J; Zhang J; Liu T; Yang F; Ren T Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614 [TBL] [Abstract][Full Text] [Related]
18. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796 [TBL] [Abstract][Full Text] [Related]
19. RNA Binding Protein-Based Model for Prognostic Prediction of Colorectal Cancer. Li T; Hui W; Halike H; Gao F Technol Cancer Res Treat; 2021; 20():15330338211019504. PubMed ID: 34080453 [TBL] [Abstract][Full Text] [Related]
20. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival. Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]